[go: up one dir, main page]

ZA923663B - Skin permeation enhancer compositions using glycerol monolinoleate - Google Patents

Skin permeation enhancer compositions using glycerol monolinoleate

Info

Publication number
ZA923663B
ZA923663B ZA923663A ZA923663A ZA923663B ZA 923663 B ZA923663 B ZA 923663B ZA 923663 A ZA923663 A ZA 923663A ZA 923663 A ZA923663 A ZA 923663A ZA 923663 B ZA923663 B ZA 923663B
Authority
ZA
South Africa
Prior art keywords
permeation enhancer
skin permeation
enhancer compositions
glycerol monolinoleate
monolinoleate
Prior art date
Application number
ZA923663A
Other languages
English (en)
Inventor
Eun Soo Lee
Soo Lee Eun
Diane E Nedberge
E Nedberge Diane
Su Ii Yum
Ii Yum Su
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ZA923663B publication Critical patent/ZA923663B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA923663A 1991-05-20 1992-05-20 Skin permeation enhancer compositions using glycerol monolinoleate ZA923663B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70344091A 1991-05-20 1991-05-20

Publications (1)

Publication Number Publication Date
ZA923663B true ZA923663B (en) 1993-01-27

Family

ID=24825405

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA923663A ZA923663B (en) 1991-05-20 1992-05-20 Skin permeation enhancer compositions using glycerol monolinoleate

Country Status (5)

Country Link
AU (1) AU2010392A (fr)
MX (1) MX9202350A (fr)
PT (1) PT100502A (fr)
WO (1) WO1992020377A1 (fr)
ZA (1) ZA923663B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736577A (en) * 1995-01-31 1998-04-07 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
EP0767659B1 (fr) * 1992-05-13 1999-10-20 Alza Corporation Administration transdermique d'oxybutynine
FR2699406B1 (fr) * 1992-12-21 1995-03-10 Commissariat Energie Atomique Films à base de copolymères, leurs applications dans des systèmes transdermiques et leurs procédés de préparation.
WO1995009007A1 (fr) * 1993-09-29 1995-04-06 Alza Corporation Renforcateur de permeation de l'oxybutine a base de monoglyceride/lactate
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US7214683B1 (en) 1994-12-30 2007-05-08 Sepracor Inc. Compositions of descarboethoxyloratadine
US7211582B1 (en) 1994-12-30 2007-05-01 Sepracor Inc. Methods for treating urticaria using descarboethoxyloratadine
US5677346A (en) * 1995-01-31 1997-10-14 Sepracor, Inc. Treating urinary incontinence using (S)-desethyloxybutynin
US5532278A (en) * 1995-01-31 1996-07-02 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
WO1998000118A2 (fr) * 1996-07-03 1998-01-08 Alza Corporation Dispositifs d'administration de medicaments et procede de fabrication
US6007837A (en) * 1996-07-03 1999-12-28 Alza Corporation Drug delivery devices and process of manufacture
KR100483913B1 (ko) * 1996-07-03 2005-09-02 알자 코포레이션 약물송달장치
US5900421A (en) * 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
US5939426A (en) * 1997-02-28 1999-08-17 Sepracor Inc. Methods for treating urinary incontinence using descarboethoxyloratadine
US6174545B1 (en) 1997-07-01 2001-01-16 Alza Corporation Drug delivery devices and process of manufacture
KR19990026792A (ko) 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
US6100274A (en) * 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US6114346A (en) * 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
AU2277101A (en) 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
WO2001045676A2 (fr) 1999-12-20 2001-06-28 Schering Corporation Composition de dose orale a liberation prolongee
US6432446B2 (en) 2000-02-03 2002-08-13 Bridge Pharma, Inc. Non-arrhythmogenic metabolite of oxybutynin
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
AU2001253782B2 (en) 2000-04-26 2006-06-29 Allergan Sales, Llc Minimizing adverse experience associated with oxybutynin therapy
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
US7029694B2 (en) 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
WO2004105692A2 (fr) 2003-05-23 2004-12-09 Bridge Pharma, Inc. Agents spasmolytiques pour muscles lisses
US20160151321A1 (en) 2012-11-13 2016-06-02 Dinesh C. Patel Methods for the treatment of sialorrhea

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5618914A (en) * 1979-07-25 1981-02-23 Eisai Co Ltd Ubidecarenone composition having good absorbability
EP0103911A1 (fr) * 1982-06-30 1984-03-28 THE PROCTER & GAMBLE COMPANY Compositions pharmaceutiques topiques contenant un agent émollient
EP0267617B1 (fr) * 1986-11-14 1992-06-24 Theratech, Inc. Augmentation du pouvoir de pénétration au moyen d'un système binaire consistant en composées modifiant l'enveloppe cellulaire et en alcools à courte chaîne
US4764379A (en) * 1987-08-24 1988-08-16 Alza Corporation Transdermal drug delivery device with dual permeation enhancers
JP2514995B2 (ja) * 1987-12-29 1996-07-10 旭電化工業株式会社 経皮、経粘膜による物質の吸収を促進する組成物
FI931916A0 (fi) * 1990-10-29 1993-04-28 Alza Corp Transdermala befruktningshindrande formuleringar, metoder och anordningar

Also Published As

Publication number Publication date
PT100502A (pt) 1993-08-31
WO1992020377A1 (fr) 1992-11-26
AU2010392A (en) 1992-12-30
MX9202350A (es) 1992-11-01

Similar Documents

Publication Publication Date Title
ZA923663B (en) Skin permeation enhancer compositions using glycerol monolinoleate
GB2212723B (en) Skin permeation enhancer compositions using glycerol monooleate
AU3247293A (en) Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
GB2274778B (en) Improved transdermal formulations
ZA926720B (en) Cosmetic composition
GB9217821D0 (en) Cosmetic composition
ZA929155B (en) Wound healing compositions and methods for preparing and using same.
GB9109733D0 (en) Cosmetic composition
ZA924533B (en) Cosmetic composition
EP0596962A4 (en) Therapeutic compositions and methods.
GB9126440D0 (en) Sunscreen compositions
ZA929774B (en) Cosmetic compositions
GB9208945D0 (en) Shampoo composition
EP0541347A3 (en) Cosmetic composition
GB9109774D0 (en) Cosmetic compositions
ZA921100B (en) Cosmetic composition
GB9101592D0 (en) Compositions
SG170994G (en) Organoleptic compositions
GB9223539D0 (en) Fuel compositions
GB9109796D0 (en) Cosmetic compositions
GB9124360D0 (en) Cosmetic compositions
GB2250432B (en) Seat enhancer
GB9109757D0 (en) Cosmetic compositions
GB9101654D0 (en) Compositions
ZA929723B (en) Formulations with hydrophobic permeation enhancer s